nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanabenz—CYP1A2—Dacarbazine—pancreatic cancer	0.0949	0.327	CbGbCtD
Guanabenz—CYP1A2—Tamoxifen—pancreatic cancer	0.0755	0.26	CbGbCtD
Guanabenz—CYP1A2—Erlotinib—pancreatic cancer	0.0642	0.221	CbGbCtD
Guanabenz—CYP1A2—Fluorouracil—pancreatic cancer	0.0556	0.192	CbGbCtD
Guanabenz—NISCH—Paclitaxel—Docetaxel—pancreatic cancer	0.0125	1	CbGdCrCtD
Guanabenz—Pain—Gemcitabine—pancreatic cancer	0.000431	0.000695	CcSEcCtD
Guanabenz—Nausea—Erlotinib—pancreatic cancer	0.000431	0.000695	CcSEcCtD
Guanabenz—Decreased appetite—Fluorouracil—pancreatic cancer	0.000431	0.000695	CcSEcCtD
Guanabenz—Diarrhoea—Sunitinib—pancreatic cancer	0.00043	0.000693	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000428	0.00069	CcSEcCtD
Guanabenz—Abdominal distension—Epirubicin—pancreatic cancer	0.000427	0.000689	CcSEcCtD
Guanabenz—Feeling abnormal—Irinotecan—pancreatic cancer	0.000427	0.000688	CcSEcCtD
Guanabenz—Influenza—Epirubicin—pancreatic cancer	0.000424	0.000684	CcSEcCtD
Guanabenz—Back pain—Docetaxel—pancreatic cancer	0.000424	0.000684	CcSEcCtD
Guanabenz—Pain—Fluorouracil—pancreatic cancer	0.000424	0.000683	CcSEcCtD
Guanabenz—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000423	0.000682	CcSEcCtD
Guanabenz—Dehydration—Doxorubicin—pancreatic cancer	0.000423	0.000681	CcSEcCtD
Guanabenz—Muscle spasms—Docetaxel—pancreatic cancer	0.000422	0.000679	CcSEcCtD
Guanabenz—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000419	0.000676	CcSEcCtD
Guanabenz—Dry skin—Doxorubicin—pancreatic cancer	0.000416	0.000671	CcSEcCtD
Guanabenz—Dizziness—Sunitinib—pancreatic cancer	0.000416	0.00067	CcSEcCtD
Guanabenz—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000416	0.00067	CcSEcCtD
Guanabenz—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000415	0.000669	CcSEcCtD
Guanabenz—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000414	0.000667	CcSEcCtD
Guanabenz—Breast disorder—Doxorubicin—pancreatic cancer	0.000411	0.000662	CcSEcCtD
Guanabenz—Abdominal pain—Irinotecan—pancreatic cancer	0.000409	0.00066	CcSEcCtD
Guanabenz—Body temperature increased—Irinotecan—pancreatic cancer	0.000409	0.00066	CcSEcCtD
Guanabenz—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000409	0.00066	CcSEcCtD
Guanabenz—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000409	0.000659	CcSEcCtD
Guanabenz—Anaemia—Docetaxel—pancreatic cancer	0.000405	0.000653	CcSEcCtD
Guanabenz—Gastritis—Doxorubicin—pancreatic cancer	0.000402	0.000648	CcSEcCtD
Guanabenz—Vomiting—Sunitinib—pancreatic cancer	0.0004	0.000644	CcSEcCtD
Guanabenz—Body temperature increased—Gemcitabine—pancreatic cancer	0.000399	0.000643	CcSEcCtD
Guanabenz—Rash—Sunitinib—pancreatic cancer	0.000396	0.000639	CcSEcCtD
Guanabenz—Dermatitis—Sunitinib—pancreatic cancer	0.000396	0.000638	CcSEcCtD
Guanabenz—Abdominal distension—Doxorubicin—pancreatic cancer	0.000395	0.000637	CcSEcCtD
Guanabenz—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000394	0.000636	CcSEcCtD
Guanabenz—Urticaria—Fluorouracil—pancreatic cancer	0.000394	0.000635	CcSEcCtD
Guanabenz—Headache—Sunitinib—pancreatic cancer	0.000394	0.000635	CcSEcCtD
Guanabenz—Syncope—Docetaxel—pancreatic cancer	0.000393	0.000634	CcSEcCtD
Guanabenz—Influenza—Doxorubicin—pancreatic cancer	0.000393	0.000633	CcSEcCtD
Guanabenz—Leukopenia—Docetaxel—pancreatic cancer	0.000392	0.000633	CcSEcCtD
Guanabenz—Body temperature increased—Fluorouracil—pancreatic cancer	0.000392	0.000632	CcSEcCtD
Guanabenz—Weight increased—Epirubicin—pancreatic cancer	0.000386	0.000623	CcSEcCtD
Guanabenz—Loss of consciousness—Docetaxel—pancreatic cancer	0.000385	0.000621	CcSEcCtD
Guanabenz—Weight decreased—Epirubicin—pancreatic cancer	0.000384	0.000619	CcSEcCtD
Guanabenz—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000383	0.000617	CcSEcCtD
Guanabenz—Cough—Docetaxel—pancreatic cancer	0.000383	0.000617	CcSEcCtD
Guanabenz—Hypersensitivity—Irinotecan—pancreatic cancer	0.000381	0.000615	CcSEcCtD
Guanabenz—Hypertension—Docetaxel—pancreatic cancer	0.000379	0.00061	CcSEcCtD
Guanabenz—Infestation NOS—Epirubicin—pancreatic cancer	0.000378	0.00061	CcSEcCtD
Guanabenz—Infestation—Epirubicin—pancreatic cancer	0.000378	0.00061	CcSEcCtD
Guanabenz—Arthralgia—Docetaxel—pancreatic cancer	0.000373	0.000602	CcSEcCtD
Guanabenz—Chest pain—Docetaxel—pancreatic cancer	0.000373	0.000602	CcSEcCtD
Guanabenz—Myalgia—Docetaxel—pancreatic cancer	0.000373	0.000602	CcSEcCtD
Guanabenz—Nausea—Sunitinib—pancreatic cancer	0.000373	0.000602	CcSEcCtD
Guanabenz—Asthenia—Irinotecan—pancreatic cancer	0.000371	0.000599	CcSEcCtD
Guanabenz—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000365	0.000589	CcSEcCtD
Guanabenz—Dry mouth—Docetaxel—pancreatic cancer	0.000365	0.000588	CcSEcCtD
Guanabenz—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000365	0.000588	CcSEcCtD
Guanabenz—Asthenia—Gemcitabine—pancreatic cancer	0.000362	0.000583	CcSEcCtD
Guanabenz—Confusional state—Docetaxel—pancreatic cancer	0.000361	0.000582	CcSEcCtD
Guanabenz—Oedema—Docetaxel—pancreatic cancer	0.000358	0.000577	CcSEcCtD
Guanabenz—Weight increased—Doxorubicin—pancreatic cancer	0.000357	0.000576	CcSEcCtD
Guanabenz—Pruritus—Gemcitabine—pancreatic cancer	0.000357	0.000575	CcSEcCtD
Guanabenz—Infection—Docetaxel—pancreatic cancer	0.000355	0.000573	CcSEcCtD
Guanabenz—Weight decreased—Doxorubicin—pancreatic cancer	0.000355	0.000573	CcSEcCtD
Guanabenz—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000354	0.000571	CcSEcCtD
Guanabenz—Diarrhoea—Irinotecan—pancreatic cancer	0.000354	0.000571	CcSEcCtD
Guanabenz—Shock—Docetaxel—pancreatic cancer	0.000352	0.000567	CcSEcCtD
Guanabenz—Nervous system disorder—Docetaxel—pancreatic cancer	0.000351	0.000566	CcSEcCtD
Guanabenz—Pruritus—Fluorouracil—pancreatic cancer	0.000351	0.000565	CcSEcCtD
Guanabenz—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00035	0.000565	CcSEcCtD
Guanabenz—Infestation—Doxorubicin—pancreatic cancer	0.00035	0.000564	CcSEcCtD
Guanabenz—Infestation NOS—Doxorubicin—pancreatic cancer	0.00035	0.000564	CcSEcCtD
Guanabenz—Tachycardia—Docetaxel—pancreatic cancer	0.000349	0.000563	CcSEcCtD
Guanabenz—Skin disorder—Docetaxel—pancreatic cancer	0.000348	0.00056	CcSEcCtD
Guanabenz—Diarrhoea—Gemcitabine—pancreatic cancer	0.000345	0.000556	CcSEcCtD
Guanabenz—Dizziness—Irinotecan—pancreatic cancer	0.000342	0.000552	CcSEcCtD
Guanabenz—Haemoglobin—Epirubicin—pancreatic cancer	0.000341	0.00055	CcSEcCtD
Guanabenz—Anorexia—Docetaxel—pancreatic cancer	0.000341	0.00055	CcSEcCtD
Guanabenz—Haemorrhage—Epirubicin—pancreatic cancer	0.00034	0.000548	CcSEcCtD
Guanabenz—Diarrhoea—Fluorouracil—pancreatic cancer	0.000339	0.000547	CcSEcCtD
Guanabenz—Oedema peripheral—Epirubicin—pancreatic cancer	0.000335	0.000539	CcSEcCtD
Guanabenz—Hypotension—Docetaxel—pancreatic cancer	0.000334	0.000539	CcSEcCtD
Guanabenz—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000334	0.000538	CcSEcCtD
Guanabenz—Vomiting—Irinotecan—pancreatic cancer	0.000329	0.000531	CcSEcCtD
Guanabenz—Dizziness—Fluorouracil—pancreatic cancer	0.000328	0.000528	CcSEcCtD
Guanabenz—Rash—Irinotecan—pancreatic cancer	0.000326	0.000526	CcSEcCtD
Guanabenz—Dermatitis—Irinotecan—pancreatic cancer	0.000326	0.000526	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000326	0.000525	CcSEcCtD
Guanabenz—Headache—Irinotecan—pancreatic cancer	0.000324	0.000523	CcSEcCtD
Guanabenz—Paraesthesia—Docetaxel—pancreatic cancer	0.000321	0.000518	CcSEcCtD
Guanabenz—Erythema multiforme—Epirubicin—pancreatic cancer	0.000321	0.000518	CcSEcCtD
Guanabenz—Vomiting—Gemcitabine—pancreatic cancer	0.000321	0.000517	CcSEcCtD
Guanabenz—Dyspnoea—Docetaxel—pancreatic cancer	0.000319	0.000514	CcSEcCtD
Guanabenz—Rash—Gemcitabine—pancreatic cancer	0.000318	0.000512	CcSEcCtD
Guanabenz—Dermatitis—Gemcitabine—pancreatic cancer	0.000318	0.000512	CcSEcCtD
Guanabenz—Eye disorder—Epirubicin—pancreatic cancer	0.000317	0.000512	CcSEcCtD
Guanabenz—Tinnitus—Epirubicin—pancreatic cancer	0.000317	0.000511	CcSEcCtD
Guanabenz—Haemoglobin—Doxorubicin—pancreatic cancer	0.000316	0.000509	CcSEcCtD
Guanabenz—Headache—Gemcitabine—pancreatic cancer	0.000316	0.000509	CcSEcCtD
Guanabenz—Vomiting—Fluorouracil—pancreatic cancer	0.000315	0.000508	CcSEcCtD
Guanabenz—Dyspepsia—Docetaxel—pancreatic cancer	0.000315	0.000508	CcSEcCtD
Guanabenz—Haemorrhage—Doxorubicin—pancreatic cancer	0.000314	0.000507	CcSEcCtD
Guanabenz—Rash—Fluorouracil—pancreatic cancer	0.000313	0.000504	CcSEcCtD
Guanabenz—Dermatitis—Fluorouracil—pancreatic cancer	0.000312	0.000503	CcSEcCtD
Guanabenz—Decreased appetite—Docetaxel—pancreatic cancer	0.000311	0.000501	CcSEcCtD
Guanabenz—Headache—Fluorouracil—pancreatic cancer	0.000311	0.000501	CcSEcCtD
Guanabenz—Oedema peripheral—Doxorubicin—pancreatic cancer	0.00031	0.000499	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000309	0.000498	CcSEcCtD
Guanabenz—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000309	0.000498	CcSEcCtD
Guanabenz—Fatigue—Docetaxel—pancreatic cancer	0.000308	0.000497	CcSEcCtD
Guanabenz—Nausea—Irinotecan—pancreatic cancer	0.000307	0.000496	CcSEcCtD
Guanabenz—Immune system disorder—Epirubicin—pancreatic cancer	0.000307	0.000495	CcSEcCtD
Guanabenz—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000306	0.000494	CcSEcCtD
Guanabenz—Pain—Docetaxel—pancreatic cancer	0.000306	0.000493	CcSEcCtD
Guanabenz—Constipation—Docetaxel—pancreatic cancer	0.000306	0.000493	CcSEcCtD
Guanabenz—Chills—Epirubicin—pancreatic cancer	0.000305	0.000491	CcSEcCtD
Guanabenz—Nausea—Gemcitabine—pancreatic cancer	0.000299	0.000483	CcSEcCtD
Guanabenz—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000297	0.000479	CcSEcCtD
Guanabenz—Erythema—Epirubicin—pancreatic cancer	0.000296	0.000477	CcSEcCtD
Guanabenz—Malnutrition—Epirubicin—pancreatic cancer	0.000296	0.000477	CcSEcCtD
Guanabenz—Feeling abnormal—Docetaxel—pancreatic cancer	0.000295	0.000475	CcSEcCtD
Guanabenz—Nausea—Fluorouracil—pancreatic cancer	0.000294	0.000475	CcSEcCtD
Guanabenz—Eye disorder—Doxorubicin—pancreatic cancer	0.000294	0.000473	CcSEcCtD
Guanabenz—Tinnitus—Doxorubicin—pancreatic cancer	0.000293	0.000472	CcSEcCtD
Guanabenz—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000293	0.000472	CcSEcCtD
Guanabenz—Flatulence—Epirubicin—pancreatic cancer	0.000291	0.00047	CcSEcCtD
Guanabenz—Tension—Epirubicin—pancreatic cancer	0.00029	0.000468	CcSEcCtD
Guanabenz—Nervousness—Epirubicin—pancreatic cancer	0.000287	0.000463	CcSEcCtD
Guanabenz—Back pain—Epirubicin—pancreatic cancer	0.000286	0.000461	CcSEcCtD
Guanabenz—Muscle spasms—Epirubicin—pancreatic cancer	0.000284	0.000458	CcSEcCtD
Guanabenz—Immune system disorder—Doxorubicin—pancreatic cancer	0.000284	0.000458	CcSEcCtD
Guanabenz—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000283	0.000457	CcSEcCtD
Guanabenz—Abdominal pain—Docetaxel—pancreatic cancer	0.000283	0.000456	CcSEcCtD
Guanabenz—Body temperature increased—Docetaxel—pancreatic cancer	0.000283	0.000456	CcSEcCtD
Guanabenz—Chills—Doxorubicin—pancreatic cancer	0.000282	0.000455	CcSEcCtD
Guanabenz—Vision blurred—Epirubicin—pancreatic cancer	0.000279	0.000449	CcSEcCtD
Guanabenz—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000274	0.000442	CcSEcCtD
Guanabenz—Malnutrition—Doxorubicin—pancreatic cancer	0.000274	0.000441	CcSEcCtD
Guanabenz—Erythema—Doxorubicin—pancreatic cancer	0.000274	0.000441	CcSEcCtD
Guanabenz—Anaemia—Epirubicin—pancreatic cancer	0.000273	0.000441	CcSEcCtD
Guanabenz—Agitation—Epirubicin—pancreatic cancer	0.000272	0.000438	CcSEcCtD
Guanabenz—Flatulence—Doxorubicin—pancreatic cancer	0.00027	0.000435	CcSEcCtD
Guanabenz—Tension—Doxorubicin—pancreatic cancer	0.000269	0.000433	CcSEcCtD
Guanabenz—Malaise—Epirubicin—pancreatic cancer	0.000267	0.00043	CcSEcCtD
Guanabenz—Nervousness—Doxorubicin—pancreatic cancer	0.000266	0.000428	CcSEcCtD
Guanabenz—Syncope—Epirubicin—pancreatic cancer	0.000265	0.000427	CcSEcCtD
Guanabenz—Leukopenia—Epirubicin—pancreatic cancer	0.000265	0.000427	CcSEcCtD
Guanabenz—Back pain—Doxorubicin—pancreatic cancer	0.000265	0.000427	CcSEcCtD
Guanabenz—Hypersensitivity—Docetaxel—pancreatic cancer	0.000264	0.000425	CcSEcCtD
Guanabenz—Muscle spasms—Doxorubicin—pancreatic cancer	0.000263	0.000424	CcSEcCtD
Guanabenz—Loss of consciousness—Epirubicin—pancreatic cancer	0.00026	0.000419	CcSEcCtD
Guanabenz—Cough—Epirubicin—pancreatic cancer	0.000258	0.000416	CcSEcCtD
Guanabenz—Vision blurred—Doxorubicin—pancreatic cancer	0.000258	0.000416	CcSEcCtD
Guanabenz—Asthenia—Docetaxel—pancreatic cancer	0.000257	0.000414	CcSEcCtD
Guanabenz—Hypertension—Epirubicin—pancreatic cancer	0.000255	0.000412	CcSEcCtD
Guanabenz—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000254	0.000409	CcSEcCtD
Guanabenz—Pruritus—Docetaxel—pancreatic cancer	0.000253	0.000408	CcSEcCtD
Guanabenz—Anaemia—Doxorubicin—pancreatic cancer	0.000253	0.000408	CcSEcCtD
Guanabenz—Chest pain—Epirubicin—pancreatic cancer	0.000252	0.000406	CcSEcCtD
Guanabenz—Arthralgia—Epirubicin—pancreatic cancer	0.000252	0.000406	CcSEcCtD
Guanabenz—Myalgia—Epirubicin—pancreatic cancer	0.000252	0.000406	CcSEcCtD
Guanabenz—Agitation—Doxorubicin—pancreatic cancer	0.000251	0.000405	CcSEcCtD
Guanabenz—Anxiety—Epirubicin—pancreatic cancer	0.000251	0.000404	CcSEcCtD
Guanabenz—Discomfort—Epirubicin—pancreatic cancer	0.000249	0.000401	CcSEcCtD
Guanabenz—Malaise—Doxorubicin—pancreatic cancer	0.000247	0.000398	CcSEcCtD
Guanabenz—Dry mouth—Epirubicin—pancreatic cancer	0.000246	0.000397	CcSEcCtD
Guanabenz—Syncope—Doxorubicin—pancreatic cancer	0.000245	0.000396	CcSEcCtD
Guanabenz—Leukopenia—Doxorubicin—pancreatic cancer	0.000245	0.000395	CcSEcCtD
Guanabenz—Diarrhoea—Docetaxel—pancreatic cancer	0.000245	0.000395	CcSEcCtD
Guanabenz—Confusional state—Epirubicin—pancreatic cancer	0.000243	0.000392	CcSEcCtD
Guanabenz—Oedema—Epirubicin—pancreatic cancer	0.000241	0.000389	CcSEcCtD
Guanabenz—Loss of consciousness—Doxorubicin—pancreatic cancer	0.00024	0.000388	CcSEcCtD
Guanabenz—Infection—Epirubicin—pancreatic cancer	0.00024	0.000386	CcSEcCtD
Guanabenz—Cough—Doxorubicin—pancreatic cancer	0.000239	0.000385	CcSEcCtD
Guanabenz—Shock—Epirubicin—pancreatic cancer	0.000237	0.000383	CcSEcCtD
Guanabenz—Nervous system disorder—Epirubicin—pancreatic cancer	0.000237	0.000382	CcSEcCtD
Guanabenz—Dizziness—Docetaxel—pancreatic cancer	0.000237	0.000381	CcSEcCtD
Guanabenz—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000236	0.000381	CcSEcCtD
Guanabenz—Hypertension—Doxorubicin—pancreatic cancer	0.000236	0.000381	CcSEcCtD
Guanabenz—Tachycardia—Epirubicin—pancreatic cancer	0.000236	0.00038	CcSEcCtD
Guanabenz—Skin disorder—Epirubicin—pancreatic cancer	0.000234	0.000378	CcSEcCtD
Guanabenz—Arthralgia—Doxorubicin—pancreatic cancer	0.000233	0.000376	CcSEcCtD
Guanabenz—Myalgia—Doxorubicin—pancreatic cancer	0.000233	0.000376	CcSEcCtD
Guanabenz—Chest pain—Doxorubicin—pancreatic cancer	0.000233	0.000376	CcSEcCtD
Guanabenz—Anxiety—Doxorubicin—pancreatic cancer	0.000232	0.000374	CcSEcCtD
Guanabenz—Discomfort—Doxorubicin—pancreatic cancer	0.00023	0.000371	CcSEcCtD
Guanabenz—Anorexia—Epirubicin—pancreatic cancer	0.00023	0.000371	CcSEcCtD
Guanabenz—Dry mouth—Doxorubicin—pancreatic cancer	0.000228	0.000367	CcSEcCtD
Guanabenz—Vomiting—Docetaxel—pancreatic cancer	0.000228	0.000367	CcSEcCtD
Guanabenz—Rash—Docetaxel—pancreatic cancer	0.000226	0.000364	CcSEcCtD
Guanabenz—Hypotension—Epirubicin—pancreatic cancer	0.000226	0.000364	CcSEcCtD
Guanabenz—Dermatitis—Docetaxel—pancreatic cancer	0.000225	0.000363	CcSEcCtD
Guanabenz—Confusional state—Doxorubicin—pancreatic cancer	0.000225	0.000363	CcSEcCtD
Guanabenz—Headache—Docetaxel—pancreatic cancer	0.000224	0.000361	CcSEcCtD
Guanabenz—Oedema—Doxorubicin—pancreatic cancer	0.000223	0.00036	CcSEcCtD
Guanabenz—Infection—Doxorubicin—pancreatic cancer	0.000222	0.000358	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.00022	0.000354	CcSEcCtD
Guanabenz—Shock—Doxorubicin—pancreatic cancer	0.00022	0.000354	CcSEcCtD
Guanabenz—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000219	0.000353	CcSEcCtD
Guanabenz—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000219	0.000352	CcSEcCtD
Guanabenz—Tachycardia—Doxorubicin—pancreatic cancer	0.000218	0.000351	CcSEcCtD
Guanabenz—Skin disorder—Doxorubicin—pancreatic cancer	0.000217	0.00035	CcSEcCtD
Guanabenz—Paraesthesia—Epirubicin—pancreatic cancer	0.000217	0.000349	CcSEcCtD
Guanabenz—Dyspnoea—Epirubicin—pancreatic cancer	0.000215	0.000347	CcSEcCtD
Guanabenz—Anorexia—Doxorubicin—pancreatic cancer	0.000213	0.000343	CcSEcCtD
Guanabenz—Nausea—Docetaxel—pancreatic cancer	0.000213	0.000343	CcSEcCtD
Guanabenz—Dyspepsia—Epirubicin—pancreatic cancer	0.000212	0.000342	CcSEcCtD
Guanabenz—Decreased appetite—Epirubicin—pancreatic cancer	0.00021	0.000338	CcSEcCtD
Guanabenz—Hypotension—Doxorubicin—pancreatic cancer	0.000209	0.000336	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000208	0.000336	CcSEcCtD
Guanabenz—Fatigue—Epirubicin—pancreatic cancer	0.000208	0.000335	CcSEcCtD
Guanabenz—Constipation—Epirubicin—pancreatic cancer	0.000206	0.000333	CcSEcCtD
Guanabenz—Pain—Epirubicin—pancreatic cancer	0.000206	0.000333	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000203	0.000328	CcSEcCtD
Guanabenz—Paraesthesia—Doxorubicin—pancreatic cancer	0.000201	0.000323	CcSEcCtD
Guanabenz—Dyspnoea—Doxorubicin—pancreatic cancer	0.000199	0.000321	CcSEcCtD
Guanabenz—Feeling abnormal—Epirubicin—pancreatic cancer	0.000199	0.000321	CcSEcCtD
Guanabenz—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000197	0.000318	CcSEcCtD
Guanabenz—Dyspepsia—Doxorubicin—pancreatic cancer	0.000197	0.000317	CcSEcCtD
Guanabenz—Decreased appetite—Doxorubicin—pancreatic cancer	0.000194	0.000313	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000193	0.000311	CcSEcCtD
Guanabenz—Fatigue—Doxorubicin—pancreatic cancer	0.000193	0.00031	CcSEcCtD
Guanabenz—Urticaria—Epirubicin—pancreatic cancer	0.000192	0.000309	CcSEcCtD
Guanabenz—Pain—Doxorubicin—pancreatic cancer	0.000191	0.000308	CcSEcCtD
Guanabenz—Constipation—Doxorubicin—pancreatic cancer	0.000191	0.000308	CcSEcCtD
Guanabenz—Abdominal pain—Epirubicin—pancreatic cancer	0.000191	0.000308	CcSEcCtD
Guanabenz—Body temperature increased—Epirubicin—pancreatic cancer	0.000191	0.000308	CcSEcCtD
Guanabenz—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000184	0.000297	CcSEcCtD
Guanabenz—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000183	0.000294	CcSEcCtD
Guanabenz—Hypersensitivity—Epirubicin—pancreatic cancer	0.000178	0.000287	CcSEcCtD
Guanabenz—Urticaria—Doxorubicin—pancreatic cancer	0.000177	0.000286	CcSEcCtD
Guanabenz—Body temperature increased—Doxorubicin—pancreatic cancer	0.000177	0.000285	CcSEcCtD
Guanabenz—Abdominal pain—Doxorubicin—pancreatic cancer	0.000177	0.000285	CcSEcCtD
Guanabenz—Asthenia—Epirubicin—pancreatic cancer	0.000173	0.000279	CcSEcCtD
Guanabenz—Pruritus—Epirubicin—pancreatic cancer	0.000171	0.000275	CcSEcCtD
Guanabenz—Diarrhoea—Epirubicin—pancreatic cancer	0.000165	0.000266	CcSEcCtD
Guanabenz—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000165	0.000265	CcSEcCtD
Guanabenz—Asthenia—Doxorubicin—pancreatic cancer	0.00016	0.000258	CcSEcCtD
Guanabenz—Dizziness—Epirubicin—pancreatic cancer	0.00016	0.000257	CcSEcCtD
Guanabenz—Pruritus—Doxorubicin—pancreatic cancer	0.000158	0.000255	CcSEcCtD
Guanabenz—Vomiting—Epirubicin—pancreatic cancer	0.000153	0.000247	CcSEcCtD
Guanabenz—Diarrhoea—Doxorubicin—pancreatic cancer	0.000153	0.000246	CcSEcCtD
Guanabenz—Rash—Epirubicin—pancreatic cancer	0.000152	0.000245	CcSEcCtD
Guanabenz—Dermatitis—Epirubicin—pancreatic cancer	0.000152	0.000245	CcSEcCtD
Guanabenz—Headache—Epirubicin—pancreatic cancer	0.000151	0.000244	CcSEcCtD
Guanabenz—Dizziness—Doxorubicin—pancreatic cancer	0.000148	0.000238	CcSEcCtD
Guanabenz—Nausea—Epirubicin—pancreatic cancer	0.000143	0.000231	CcSEcCtD
Guanabenz—Vomiting—Doxorubicin—pancreatic cancer	0.000142	0.000229	CcSEcCtD
Guanabenz—Rash—Doxorubicin—pancreatic cancer	0.000141	0.000227	CcSEcCtD
Guanabenz—Dermatitis—Doxorubicin—pancreatic cancer	0.000141	0.000227	CcSEcCtD
Guanabenz—Headache—Doxorubicin—pancreatic cancer	0.00014	0.000226	CcSEcCtD
Guanabenz—Nausea—Doxorubicin—pancreatic cancer	0.000133	0.000214	CcSEcCtD
Guanabenz—ADRA2B—Signaling Pathways—JAG1—pancreatic cancer	4.38e-05	0.000569	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CNR2—pancreatic cancer	4.36e-05	0.000567	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—GLP1R—pancreatic cancer	4.36e-05	0.000567	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR ligand binding—CXCL8—pancreatic cancer	4.36e-05	0.000567	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—NOTCH3—pancreatic cancer	4.36e-05	0.000566	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CCKAR—pancreatic cancer	4.29e-05	0.000558	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—SRC—pancreatic cancer	4.29e-05	0.000557	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—STK11—pancreatic cancer	4.19e-05	0.000544	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—SST—pancreatic cancer	4.18e-05	0.000543	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—VEGFA—pancreatic cancer	4.18e-05	0.000542	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—JAG2—pancreatic cancer	4.16e-05	0.000541	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CNR1—pancreatic cancer	4.13e-05	0.000536	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—NRAS—pancreatic cancer	4.12e-05	0.000536	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—PIK3CG—pancreatic cancer	4.12e-05	0.000535	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MEN1—pancreatic cancer	4.1e-05	0.000533	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ARG2—pancreatic cancer	4.09e-05	0.000531	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—JAG1—pancreatic cancer	4.09e-05	0.000531	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NOTCH3—pancreatic cancer	4.07e-05	0.000529	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—PIK3CB—pancreatic cancer	4.06e-05	0.000527	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—PIK3CG—pancreatic cancer	4.01e-05	0.000521	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—SRC—pancreatic cancer	4e-05	0.00052	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—GCG—pancreatic cancer	3.99e-05	0.000518	CbGpPWpGaD
Guanabenz—ADRA2A—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	3.92e-05	0.000509	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—SHH—pancreatic cancer	3.91e-05	0.000509	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—VEGFA—pancreatic cancer	3.9e-05	0.000507	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NOTCH4—pancreatic cancer	3.89e-05	0.000505	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—PIK3CD—pancreatic cancer	3.88e-05	0.000504	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IAPP—pancreatic cancer	3.87e-05	0.000502	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CNR1—pancreatic cancer	3.86e-05	0.000501	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—NRAS—pancreatic cancer	3.85e-05	0.000501	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—TGFB1—pancreatic cancer	3.83e-05	0.000498	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—AGTR1—pancreatic cancer	3.8e-05	0.000494	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—CD44—pancreatic cancer	3.77e-05	0.00049	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—STK11—pancreatic cancer	3.75e-05	0.000487	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—PIK3CG—pancreatic cancer	3.74e-05	0.000486	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—GCG—pancreatic cancer	3.72e-05	0.000484	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PTHLH—pancreatic cancer	3.71e-05	0.000482	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PTCH1—pancreatic cancer	3.71e-05	0.000482	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—PIK3CD—pancreatic cancer	3.62e-05	0.000471	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—GCG—pancreatic cancer	3.62e-05	0.00047	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—TYMS—pancreatic cancer	3.6e-05	0.000468	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—TGFB1—pancreatic cancer	3.58e-05	0.000465	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—TYMP—pancreatic cancer	3.57e-05	0.000464	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—AGTR1—pancreatic cancer	3.55e-05	0.000462	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—KRAS—pancreatic cancer	3.55e-05	0.000461	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—PIK3CD—pancreatic cancer	3.52e-05	0.000458	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—STK11—pancreatic cancer	3.5e-05	0.000455	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—STK11—pancreatic cancer	3.4e-05	0.000442	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—SST—pancreatic cancer	3.39e-05	0.000441	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—PIK3CB—pancreatic cancer	3.38e-05	0.000439	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—PIK3CG—pancreatic cancer	3.35e-05	0.000435	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—JAG1—pancreatic cancer	3.32e-05	0.000432	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—KRAS—pancreatic cancer	3.32e-05	0.000431	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NOTCH3—pancreatic cancer	3.31e-05	0.00043	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—PIK3CD—pancreatic cancer	3.29e-05	0.000427	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—SMAD4—pancreatic cancer	3.28e-05	0.000427	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—PIK3CA—pancreatic cancer	3.26e-05	0.000424	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—SRC—pancreatic cancer	3.25e-05	0.000423	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—CXCL8—pancreatic cancer	3.25e-05	0.000422	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—HES1—pancreatic cancer	3.21e-05	0.000417	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—VEGFA—pancreatic cancer	3.17e-05	0.000412	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—PIK3CB—pancreatic cancer	3.16e-05	0.00041	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—TP53—pancreatic cancer	3.15e-05	0.00041	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CNR1—pancreatic cancer	3.13e-05	0.000407	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—NRAS—pancreatic cancer	3.13e-05	0.000407	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—PIK3CB—pancreatic cancer	3.07e-05	0.000399	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—SMAD4—pancreatic cancer	3.07e-05	0.000398	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—PIK3CA—pancreatic cancer	3.05e-05	0.000396	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—PIK3CG—pancreatic cancer	3.04e-05	0.000395	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—CXCL8—pancreatic cancer	3.03e-05	0.000394	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—GCG—pancreatic cancer	3.03e-05	0.000393	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—HRAS—pancreatic cancer	3.02e-05	0.000392	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—HES1—pancreatic cancer	2.99e-05	0.000389	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—CXCL8—pancreatic cancer	2.95e-05	0.000383	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.95e-05	0.000383	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—TP53—pancreatic cancer	2.95e-05	0.000383	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.94e-05	0.000382	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—APOE—pancreatic cancer	2.93e-05	0.000381	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—TYMS—pancreatic cancer	2.93e-05	0.00038	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—TGFB1—pancreatic cancer	2.91e-05	0.000378	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—AGTR1—pancreatic cancer	2.89e-05	0.000375	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GLP1R—pancreatic cancer	2.88e-05	0.000374	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—PIK3CB—pancreatic cancer	2.87e-05	0.000373	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—STK11—pancreatic cancer	2.84e-05	0.00037	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—DPYD—pancreatic cancer	2.83e-05	0.000368	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—HRAS—pancreatic cancer	2.82e-05	0.000366	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—TERT—pancreatic cancer	2.81e-05	0.000365	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—CXCL8—pancreatic cancer	2.76e-05	0.000358	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—KRAS—pancreatic cancer	2.69e-05	0.00035	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	2.69e-05	0.000349	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—HIF1A—pancreatic cancer	2.69e-05	0.000349	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—TSC2—pancreatic cancer	2.68e-05	0.000348	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—PIK3CD—pancreatic cancer	2.67e-05	0.000347	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—AKT1—pancreatic cancer	2.66e-05	0.000346	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.66e-05	0.000346	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PIK3CG—pancreatic cancer	2.64e-05	0.000344	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—TERT—pancreatic cancer	2.62e-05	0.000341	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—APOE—pancreatic cancer	2.62e-05	0.000341	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—KDR—pancreatic cancer	2.57e-05	0.000334	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.57e-05	0.000334	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.56e-05	0.000333	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PPARG—pancreatic cancer	2.55e-05	0.000332	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—HIF1A—pancreatic cancer	2.51e-05	0.000326	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—TSC2—pancreatic cancer	2.5e-05	0.000325	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—SMAD4—pancreatic cancer	2.49e-05	0.000324	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—AKT1—pancreatic cancer	2.49e-05	0.000323	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—PIK3CA—pancreatic cancer	2.47e-05	0.000321	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—CXCL8—pancreatic cancer	2.46e-05	0.00032	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—APOE—pancreatic cancer	2.45e-05	0.000318	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—NFKBIA—pancreatic cancer	2.44e-05	0.000318	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—HES1—pancreatic cancer	2.43e-05	0.000316	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—NOTCH1—pancreatic cancer	2.42e-05	0.000314	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—KDR—pancreatic cancer	2.4e-05	0.000312	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—TP53—pancreatic cancer	2.39e-05	0.000311	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—APOE—pancreatic cancer	2.38e-05	0.000309	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PIK3CG—pancreatic cancer	2.37e-05	0.000308	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—NRAS—pancreatic cancer	2.37e-05	0.000308	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.34e-05	0.000304	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—EGF—pancreatic cancer	2.34e-05	0.000304	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—PIK3CB—pancreatic cancer	2.33e-05	0.000303	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PIK3CD—pancreatic cancer	2.32e-05	0.000302	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—HRAS—pancreatic cancer	2.29e-05	0.000297	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NFKBIA—pancreatic cancer	2.28e-05	0.000297	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NOTCH1—pancreatic cancer	2.26e-05	0.000294	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CXCL8—pancreatic cancer	2.24e-05	0.000291	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PIK3CG—pancreatic cancer	2.21e-05	0.000287	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—NRAS—pancreatic cancer	2.21e-05	0.000287	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—EGF—pancreatic cancer	2.19e-05	0.000284	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—EGFR—pancreatic cancer	2.16e-05	0.00028	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PIK3CG—pancreatic cancer	2.15e-05	0.000279	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TERT—pancreatic cancer	2.13e-05	0.000277	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CD44—pancreatic cancer	2.08e-05	0.000271	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PIK3CD—pancreatic cancer	2.08e-05	0.00027	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PPARG—pancreatic cancer	2.07e-05	0.000269	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.06e-05	0.000268	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.04e-05	0.000265	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—HIF1A—pancreatic cancer	2.04e-05	0.000265	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—KRAS—pancreatic cancer	2.04e-05	0.000265	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TSC2—pancreatic cancer	2.03e-05	0.000264	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PIK3CB—pancreatic cancer	2.03e-05	0.000263	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—AKT1—pancreatic cancer	2.02e-05	0.000263	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.02e-05	0.000263	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—EGFR—pancreatic cancer	2.01e-05	0.000262	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PTGS2—pancreatic cancer	2.01e-05	0.000261	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GCG—pancreatic cancer	2e-05	0.000259	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—APOE—pancreatic cancer	1.99e-05	0.000259	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—KDR—pancreatic cancer	1.95e-05	0.000253	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PIK3CD—pancreatic cancer	1.94e-05	0.000253	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.93e-05	0.00025	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—KRAS—pancreatic cancer	1.9e-05	0.000247	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PIK3CD—pancreatic cancer	1.89e-05	0.000245	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—STK11—pancreatic cancer	1.88e-05	0.000244	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—PIK3CA—pancreatic cancer	1.87e-05	0.000243	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NFKBIA—pancreatic cancer	1.85e-05	0.000241	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NOTCH1—pancreatic cancer	1.84e-05	0.000239	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PIK3CB—pancreatic cancer	1.81e-05	0.000236	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PIK3CG—pancreatic cancer	1.8e-05	0.000233	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—NRAS—pancreatic cancer	1.8e-05	0.000233	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—EGF—pancreatic cancer	1.77e-05	0.000231	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.76e-05	0.000229	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PTEN—pancreatic cancer	1.75e-05	0.000227	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—PIK3CA—pancreatic cancer	1.75e-05	0.000227	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CXCL8—pancreatic cancer	1.74e-05	0.000226	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—HRAS—pancreatic cancer	1.73e-05	0.000225	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PIK3CB—pancreatic cancer	1.69e-05	0.00022	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—AKT1—pancreatic cancer	1.68e-05	0.000219	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CASP3—pancreatic cancer	1.67e-05	0.000217	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PIK3CB—pancreatic cancer	1.65e-05	0.000214	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—EGFR—pancreatic cancer	1.64e-05	0.000213	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PTGS2—pancreatic cancer	1.63e-05	0.000212	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CXCL8—pancreatic cancer	1.63e-05	0.000212	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CCND1—pancreatic cancer	1.62e-05	0.000211	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—HRAS—pancreatic cancer	1.62e-05	0.00021	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—TYMS—pancreatic cancer	1.62e-05	0.00021	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CTNNB1—pancreatic cancer	1.61e-05	0.000209	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PIK3CD—pancreatic cancer	1.58e-05	0.000205	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MMP9—pancreatic cancer	1.58e-05	0.000205	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—AKT1—pancreatic cancer	1.57e-05	0.000204	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PTEN—pancreatic cancer	1.57e-05	0.000204	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.56e-05	0.000203	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CASP3—pancreatic cancer	1.56e-05	0.000202	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—KRAS—pancreatic cancer	1.55e-05	0.000201	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—AKT1—pancreatic cancer	1.53e-05	0.000199	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CCND1—pancreatic cancer	1.52e-05	0.000197	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CTNNB1—pancreatic cancer	1.5e-05	0.000195	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MMP9—pancreatic cancer	1.47e-05	0.000191	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PTEN—pancreatic cancer	1.46e-05	0.00019	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—SRC—pancreatic cancer	1.45e-05	0.000189	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—AKT1—pancreatic cancer	1.43e-05	0.000186	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PTEN—pancreatic cancer	1.42e-05	0.000185	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—PIK3CA—pancreatic cancer	1.42e-05	0.000184	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—VEGFA—pancreatic cancer	1.42e-05	0.000184	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—STAT3—pancreatic cancer	1.4e-05	0.000182	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—NRAS—pancreatic cancer	1.4e-05	0.000182	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PIK3CB—pancreatic cancer	1.38e-05	0.000179	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—SRC—pancreatic cancer	1.36e-05	0.000176	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CXCL8—pancreatic cancer	1.32e-05	0.000172	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—VEGFA—pancreatic cancer	1.32e-05	0.000172	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—HRAS—pancreatic cancer	1.31e-05	0.000171	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—APOE—pancreatic cancer	1.31e-05	0.000171	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—STAT3—pancreatic cancer	1.31e-05	0.00017	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NRAS—pancreatic cancer	1.31e-05	0.00017	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MYC—pancreatic cancer	1.3e-05	0.000169	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—TGFB1—pancreatic cancer	1.3e-05	0.000169	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—AKT1—pancreatic cancer	1.28e-05	0.000166	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—EGFR—pancreatic cancer	1.27e-05	0.000166	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CASP3—pancreatic cancer	1.27e-05	0.000164	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.24e-05	0.000162	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PIK3CA—pancreatic cancer	1.23e-05	0.00016	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CCND1—pancreatic cancer	1.23e-05	0.00016	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CTNNB1—pancreatic cancer	1.22e-05	0.000159	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MYC—pancreatic cancer	1.22e-05	0.000158	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—TGFB1—pancreatic cancer	1.21e-05	0.000158	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—KRAS—pancreatic cancer	1.2e-05	0.000156	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MMP9—pancreatic cancer	1.2e-05	0.000155	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—EGFR—pancreatic cancer	1.19e-05	0.000155	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PTEN—pancreatic cancer	1.19e-05	0.000154	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	1.19e-05	0.000154	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—AKT1—pancreatic cancer	1.16e-05	0.000151	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PPARG—pancreatic cancer	1.14e-05	0.000149	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—KRAS—pancreatic cancer	1.12e-05	0.000146	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PIK3CA—pancreatic cancer	1.11e-05	0.000144	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—SRC—pancreatic cancer	1.1e-05	0.000143	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—VEGFA—pancreatic cancer	1.07e-05	0.00014	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—TP53—pancreatic cancer	1.07e-05	0.000139	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—STAT3—pancreatic cancer	1.06e-05	0.000138	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NRAS—pancreatic cancer	1.06e-05	0.000138	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	1.04e-05	0.000135	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PIK3CA—pancreatic cancer	1.03e-05	0.000134	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—HRAS—pancreatic cancer	1.02e-05	0.000133	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—AKT1—pancreatic cancer	1.01e-05	0.000131	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PIK3CA—pancreatic cancer	1e-05	0.00013	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—TP53—pancreatic cancer	9.99e-06	0.00013	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MYC—pancreatic cancer	9.88e-06	0.000128	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TGFB1—pancreatic cancer	9.86e-06	0.000128	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—EGFR—pancreatic cancer	9.66e-06	0.000126	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—HRAS—pancreatic cancer	9.55e-06	0.000124	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—KRAS—pancreatic cancer	9.13e-06	0.000119	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	9.08e-06	0.000118	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—AKT1—pancreatic cancer	9.03e-06	0.000117	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PTGS2—pancreatic cancer	9e-06	0.000117	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—AKT1—pancreatic cancer	8.44e-06	0.00011	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PIK3CA—pancreatic cancer	8.39e-06	0.000109	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—AKT1—pancreatic cancer	8.19e-06	0.000106	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TP53—pancreatic cancer	8.11e-06	0.000105	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PTEN—pancreatic cancer	7.85e-06	0.000102	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—HRAS—pancreatic cancer	7.76e-06	0.000101	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—AKT1—pancreatic cancer	6.85e-06	8.9e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	5.54e-06	7.2e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—AKT1—pancreatic cancer	4.52e-06	5.88e-05	CbGpPWpGaD
